GloGlo

GloGlo is a San Francisco-based company using artificial intelligence and experimental biology to advance research into autoimmune diseases, beginning with type 1 diabetes. Founded by Marie Schneegans and Michael Fester, and backed by Y Combinator, the company combines AI research agents, computational models, and experimental data to investigate how insulin production might be restored and the immune system’s attack on pancreatic beta cells stopped. Its research includes growing functional beta cells from stem cells, identifying molecules recognized by T cells, and exploring cell replacement, immune tolerance, and selective treatments.

Alongside its long-term research goal, GloGlo offers consumer products intended to support people living with diabetes today. GloGlo Gummies are dextrose gummies designed to raise low blood sugar quickly and are available through Amazon, TikTok Shop, and selected retailers. The GloGlo AI app, available for iPhone and Android, helps users track food, estimate carbohydrate content from photos, and receive personalized AI coaching to support more time in their target glucose range.